raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:64741

Pulmonary blastoma

Synonyms: Pneumoblastoma

Type
Disease
Group
Disorder
Inheritance
Multigenic/multifactorial
Age of onset
Adult
Status
active

A biphasic primary lung neoplasm, belonging to the group of sarcomatoid lung carcinomas (SLCs). The tumor contains both an epithelial well-differentiated component, showing tubular architecture resembling the normal fetal lung, and a mesenchymal undifferentiated stroma with a so-called ''blastema-like'' configuration that resembles an embryonic lung.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPulmonary blastomaPneumoblastoma
frBlastome pulmonairePneumoblastome
dePulmonales BlastomPneumoblastom
esBlastoma pulmonar= en
itBlastoma polmonare= en
nlPulmonaal blastoomPneumoblastoom
ptPneumoblastomaBlastoma pulmonar
plBlastoma płuc= en
csPlicní blastomPneumoblastom
ukБластома легеньПневмобластома
zh肺胚细胞瘤肺母细胞瘤
trPulmoner blastomPnömoblastom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C34.1BTNTattributedvalidated
ICD-10C34.2BTNTattributedvalidated
ICD-10C34.3BTNTattributedvalidated
ICD-10C34.8BTNTattributedvalidated
ICD-10C34.9BTNTattributedvalidated
ICD-112C25.YNTBTindexvalidated
ICD-11XH5VH1Especificvalidated
MONDO0005933Evalidated
MeSHD018202Evalidated
UMLSC0206629Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

8 records
TypeClassValueAreaQualificationValidationSource
Cases/families350 casesWorldwideCase(s)Validated[EXPERT]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET
Annual incidence<1 / 1 000 000—EuropeClass onlyValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.002 / 100 000BelgiumValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.005 / 100 000FinlandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.001 / 100 000GermanyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.002 / 100 000ItalyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.002 / 100 000NetherlandsValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

9 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0100749Chest pain
HP:0012735Cough
HP:0002105Hemoptysis
HP:0100528Pleuropulmonary blastoma
HP:0002113Pulmonary infiltrates
Frequent (79-30%)
HP:0002094Dyspnea
HP:0001945Fever
HP:0006532Recurrent pneumonia
HP:0001824Weight loss

Run the differential on the 5 obligate / very frequent terms

7

Sources for this card